Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 926, Issue , 2013, Pages 83-91

  Andriamanana, Irina ^a   Gana, Ines ^a   Duretz, Bénédicte ^b   Hulin, Anne ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Thermo Fisher Scientific   (United States)

Author keywords

Anticancer targeted therapy; LC MS MS; Tyrosine kinase inhibitor

Indexed keywords

ANTICANCER TARGETED THERAPY; LC-MS/MS; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); PHARMACOKINETICS AND PHARMACODYNAMICS; SELECTED REACTION MONITORING; SIMULTANEOUS DETERMINATIONS; TRIPLE-QUADRUPOLE MASS SPECTROMETRY; TYROSINE KINASE INHIBITOR;

AMINO ACIDS; ELECTROSPRAY IONIZATION; FORMIC ACID; LINEAR REGRESSION; LIQUID CHROMATOGRAPHY; PHYSICAL THERAPY; PLASMA (HUMAN);

MASS SPECTROMETRY;

ACETONITRILE; AMMONIUM FORMATE; BORTEZOMIB; DASATINIB; ERLOTINIB; FORMIC ACID; IMATINIB; LAPATINIB; NILOTINIB; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; VANDETANIB;

ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; FLOW RATE; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MEASUREMENT ACCURACY; PRECIPITATION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; SENSITIVITY AND SPECIFICITY; SUPERNATANT; TANDEM MASS SPECTROMETRY;

ANTINEOPLASTIC AGENTS; BENZAMIDES; BORONIC ACIDS; CHROMATOGRAPHY, LIQUID; HUMANS; INDOLES; NIACINAMIDE; PHENYLUREA COMPOUNDS; PIPERAZINES; PIPERIDINES; PYRAZINES; PYRIMIDINES; PYRROLES; QUINAZOLINES; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; THIAZOLES;

EID: 84876016205     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.01.037     Document Type: Article

References (51)

1. Steeghs N., Nortier J.W., Gelderblom H. Ann. Surg. Oncol. 2007, 14:942.
2. Druker B.J., Sawyers C.L., Kantarjian H., Resta D.J., Reese S.F., Ford J.M., Capdeville R., Talpaz M. N. Engl. J. Med. 2001, 344:1038.
3. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C.L. N. Engl. J. Med. 2001, 344:1031.
4. Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., Heinrich M.C., Tuveson D.A., Singer S., Janicek M., Fletcher J.A., Silverman S.G., Silberman S.L., Capdeville R., Kiese B., Peng B., Dimitrijevic S., Druker B.J., Corless C., Fletcher C.D.M., Joensuu H. N. Engl. J. Med. 2002, 347:472.
5. Lahaye T., Riehm B., Berger U., Paschka P., Muller M.C., Kreil S., Merx K., Schwindel U., Schoch C., Hehlmann R., Hochhaus A. Cancer 2005, 103:1659.
6. Deininger M., Buchdunger E., Druler B.J. Blood 2005, 105:2640.
7. Heinrich M.C., Corless C.L., Demetri G.D., Blanke C.D., von Mehren M., Joensuu H., McGreevey L.S., Chen C.J., Van den Abbeele A.D., Druker B.J., Kiese B., Eisenberg B., Roberts P.J., Singer S., Fletcher C.D.M., Silberman S.L., Dimitrijevic S., Fletcher J.A. J. Clin. Oncol. 2003, 21:4342.
8. Apperley J.F., Cortes J.E., Kim D.W., Roy L., Roboz G.J., Rosti G., Bullorsky E.O., Abruzzese E., Hochhaus A., Heim D., de Souza C.A., Larson R.A., Lipton J.H., Khoury H.J., Kim H.J., Sillaber C., Hughes T.P., Erben P., Van Tornout J., Stone R.M. J. Clin. Oncol. 2009, 27:3472.
9. Quintas-Cardama A., Kantarjian H., Cortes J. Nat. Rev. Drug Discov. 2007, 6:834.
10. Quintas-Cardama A., Cortes J. Drugs Today (Barc.) 2007, 43:691.
11. Hazarika M., Jiang X., Liu Q., Lee S.L., Ramchandani R., Garnett C., Orr M.S., Sridhara R., Booth B., Leighton J.K., TiMWer W., Harapanhalli R., Daghter R., Justice R., Pazdur R. Clin. Cancer Res. 2008, 14:5325.
12. Teicher B.A., Ara G., Herbst R., Palombella V.J., Adams J. Clin. Cancer Res. 1999, 5:2638.
13. Goy A., Younes A., McLaughlin P., Pro B., Romaguera J.E., Hagemeister F., Fayad L., Dang N.H., Samaniego F., Wang M., Broglio K., Samuels B., Gilles F., Sarris A.H., Hart S., Trehu E., Schenkein D., Cabanillas F., Rodriguez A.M. J. Clin. Oncol. 2005, 23:667.
14. O'Connor O.A., Wright J., Moskowitz C., Muzzy J., MacGregor-Cortelli B., Stubblefield M., Straus D., Portlock C., Hamlin P., Choi E., Dumetrescu O., Esseltine D., Trehu E., Adams J., Schenkein D., Zelenetz A.D. J. Clin. Oncol. 2005, 23:676.
15. Eisenberg B.L., Trent J.C.J.C. Int. J. Cancer 2011, 129:2533.
16. Maleddu A., Pantaleo M.A., Nannini M., Biasco G. J. Transl. Med. 2011, 9:75.
17. Reichardt P., Reichardt A., Pink D. Curr. Cancer Drug Targets 2011, 11:688.
18. Ciardiello F., Tortora G. Clin. Cancer Res. 2001, 7:2958.
19. Rusnak D.W., Lackey K., Affleck K., Wood E.R., Alligood K.J., Rhodes N., Keith B.R., Murray D.M., Knight W.B., Mullin R.J., Gilmer T.M. Mol. Cancer Ther. 2001, 1:85.
20. Xia W., Mullin R.J., Keith B.R., Liu L.H., Ma H., Rusnak D.W., Owens G., Alligood K.J., Spector N.L. Oncogene 2002, 21:6255.
21. Rusnak D.W., Affleck K., Cockerill S.G., Stubberfield C., Harris R., Page M., Smith K.J., Guntrip S.B., Carter M.C., Shaw R.J., Jowett A., Stables J., Topley P., Wood E.R., Brignola P.S., Kadwell S.H., Reep B.R., Mullin R.J., Alligood K.J., Keith B.R., Crosby R.M., Murray D.M., Knight W.B., Gilmer T.M., Lackey K. Cancer Res. 2001, 61:7196.
22. Cockerill S.G., Stubberfield C., Stables J., Carter M.C., Guntrip S.B., Smith K.J., McKeown S., Shaw R.J., Topley P., Thomsen L., Affleck K., Jowett A., Hayes D., Willson M., Woollard P., Spalding D. Bioorg. Med. Chem. Lett. 2001, 11:1401.
23. Burriss H.A. Oncologist 2004, 9(Suppl. 3):10.
24. Pirrotta M.T., Bernardeschi P., Fiorentini G. Curr. Med. Chem. 2011, 18:1651.
25. Escudier B., Eisen T., Stadle W.M., Szczylik C., Oudard S., Siebels M., Negrier S., Chevreau C., Solska E., Desai A.A. N. Engl. J. Med. 2007, 356:125.
26. Wilhelm S.M., Carter C., Tang L., Wilkie D., McNabola A., Rong H., Chen C., Zhang X., Vincent P., McHugh M. Cancer Res. 2004, 64:7099.
27. Chang Y.S., Adnane J., Trail P.A., Levy J., Henderson A., Xu D., Bortolon E., Ichetovkin M., Chen C., McNabola A. Cancer Chemother. Pharmacol. 2007, 59:561.
28. Sequist L.V., Joshi V.A., Jänne P.A., Bell D.W., Fidias P., Lindeman N.I., Louis D.N., Lee J.C., Mark E.J., Longtine J., Verlander P., Kucherlapati R., Meyerson M., Haber D.A., Johnson B.E., Lynch T.J. Clin. Cancer Res. 2006, 12:4403s.
29. Paez J.G., Jänne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F.J., Lindeman N., Boggon T.J., Naoki K., Sasaki H., Fujii Y., Eck M.J., Sellers W.R., Johnson B.E., Meyerson M. Science 2004, 304:1497.
30. Pao W., Miller V.A., Venkatraman E., Kris M.G. J. Natl. Cancer Inst. 2004, 96:1117-1119.
31. Ryan A.J., Wedge S.R. Br. J. Cancer 2005, 92:S6.
32. Gustafson D.L., Frederick B., Merz A.L., Raben D. Cancer Chemother. Pharmacol. 2008, 61:179.
33. Parise R.A., Egorin M.J., Christner S.M., Shah D.D., Zhou W., Beumer J.H. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:1894.
34. Bai F., Freeman B.B., Fraga C.H., Fouladi M., Stewart C.F. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, 831:169.
35. Minkin P., Zhao M., Chen Z., Ouwerkerk J., Gelderblom H., Baker S.D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 874:84.
36. Jain L., Gardner E.R., Venitz J., Dahut W., Figg W.D. J. Pharm. Biomed. Anal. 2008, 46:362.
37. Zirrolli J.A., Bradshaw E.L., Long M.E., Gustafson D.L. J. Pharm. Biomed. Anal. 2005, 39:705.
38. Sparidans R.W., Iusuf D., Schinkel A.H., Schellens J.H., Beijnen J.H. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:4090.
39. Götze L., Hegele A., Metzelder S.K., Renz H., Nockher W.A. Clin. Chim. Acta 2012, 413(1-2):143-149.
40. Bouchet S., Chauzit E., Ducint D., Castaing N., Canal-Raffin M., Moore N., Titier K., Molimard M. Clin. Chim. Acta 2011, 12:1060.
41. Couchman L., Birch M., ireland R., corrigan A., Wickramasinghe S., josephs D., Spicer J., Flanagan R.J. Anal. Bioanal. Chem. 2012, 403:1685.
42. Roche S., McMahon G., Clynes M., O'Connor R. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:3982.
43. Hsieh Y., Galviz G., Zhou Q., Duncan C. Rapid Commun. Mass Spectrom. 2009, 23:1364.
44. Haouala A., Zanolari B., Rochat B., Montemurro M., Zaman K., Duchosal M.A., Ris H.B., Leyvraz S., Widmer N., Decosterd L.A. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:1982.
45. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., Weiner R. AAPS J. 2007, 9:E30.
46. Food and Drug Administration, Guidance for Industry - Bioanalytical Method Validation, . http://www.fda.gov/cder/guidance/4252fnl.pdf.2001.
47. Peters F.T., DruMWer O.H., Musshoff F. Forensic Sci. Int. 2007, 165:216.
48. Matuszewski B.K. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, 830:293.
49. Commission Directive 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results, Official Journal L221/8.
50. Mahon F.X.F.X., Molimard M. Leuk. Res. 2009, 33(8):1147.
51. Faivre S., Delbaldo C., Vera K., Robert C., Lozahic S., Lassau N., Bello C., Deprimo S., Brega N., Massimini G., Armand J.P., Scigalla P., Raymond E. J. Clin. Oncol. 2006, 24(1):25.